Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 19 - Number 7

Review Article

Personalizing Psychological Treatment Along the IBD Journey: From Diagnosis to Surgery

, 19(7): 722 - 728

Julia Menichetti*, Gionata Fiorino and Elena Vegni

DOI: 10.2174/1389450118666170502142939

Review Article

Postoperative Approach for Crohn's Disease: The Right Therapy to the Right Patient

, 19(7): 729 - 739

Paulo Gustavo Kotze*, Takayuki Yamamoto and Aderson O.M.C. Damiao

DOI: 10.2174/1389450116666151102094922

Review Article

Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach

, 19(7): 740 - 747

Parambir S. Dulai and Corey A. Siegel*

DOI: 10.2174/1389450118666170525114939

Review Article

Biologic therapies in ulcerative colitis: primi inter pares?

, 19(7): 748 - 756

Mariangela Allocca, Gionata Fiorino, Daniela Gilardi, Paoletta Preatoni, Alfredo Papa, Laurent Peyrin-Biroulet and Silvio Danese*

DOI: 10.2174/1389450117666160527142719

Review Article

Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment

, 19(7): 757 - 776

Erwin Dreesen, Ann Gils and Severine Vermeire*

DOI: 10.2174/1389450117666160307144329

Review Article

Can we Monitor a Patient with Inflammatory Bowel Disease and Adapt Treatment without Endoscopy?

, 19(7): 777 - 781

Julian Panes* and Elena Ricart

DOI: 10.2174/1389450117666160401125642

Review Article

Evolving Treatment Algorithms in Crohn's Disease

, 19(7): 782 - 790

Andrew Wisniewski, Silvio Danese and Laurent Peyrin-Biroulet*

DOI: 10.2174/1389450117666160607075557

Review Article

Can we Predict Disease Course with Clinical Factors?

, 19(7): 791 - 797

Zsuzsanna Vegh, Zsuzsanna Kurti, Petra A. Golovics and Peter L. Lakatos*

DOI: 10.2174/1389450118666170329095123

Review Article

Can Surgery for Inflammatory Bowel Disease be Personalized?

, 19(7): 798 - 804

Antonino Spinelli*, Alessandra Marano, Claudio Bacchelli, Nicolo Maria Mariani, Marco Montorsi and Paulo Gustavo Kotze

DOI: 10.2174/1389450118666170105153646

Review Article

Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod

, 19(7): 805 - 814

Zsofia Majlath, Adam Annus and Laszlo Vecsei*

DOI: 10.2174/1389450117666161223125417

Review Article

Designing Isoform-selective Inhibitors Against Classical HDACs for Effective Anticancer Therapy: Insight and Perspectives from In Silico

, 19(7): 815 - 824

Shabir Ahmad Ganai*

DOI: 10.2174/1389450118666170112130151

Review Article

Early Urinary Markers for Diabetic and Other Kidney Diseases

, 19(7): 825 - 831

Vikram Thakur and Munmun Chattopadhyay*

DOI: 10.2174/1389450119666180319124639

Review Article

Main Isoflavones Found in Dietary Sources as Natural Anti-inflammatory Agents

, 19(7): 841 - 853

Corina Danciu*, Stefana Avram, Ioana Zinuca Pavel, Roxana Ghiulai, Cristina Adriana Dehelean, Alexa Ersilia, Daliana Minda, Cristina Petrescu*, Elena-Alina Moaca and Codruta Soica

DOI: 10.2174/1389450118666171109150731


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog